Lexeo Therapeutics
LXEO
LXEO
90 hedge funds and large institutions have $194M invested in Lexeo Therapeutics in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.68% less ownership
Funds ownership: 89.94% → 89.26% (-0.68%)
28% less capital invested
Capital invested by funds: $269M → $194M (-$74.6M)
Holders
90
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.54M | |
| 2 | +$3.19M | |
| 3 | +$2.99M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$2.76M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2M |
Top Sellers
| 1 | -$9.23M | |
| 2 | -$6.59M | |
| 3 | -$4.89M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.06M |
| 5 |
DCP
D1 Capital Partners
New York
|
-$2.38M |